A new type of computer combining human neurons and silicon has just hit the market. This system, developed by an Australian ...

Over the past decade, intensive studies have shown that the brain's meningeal lymphatic system acts as the brain's "waste ...

Patients with vs without central sensitization syndrome had significantly more severe autonomic and sensory symptoms.

License agreement and recent leadership appointments position Cassava to advance development of simufilam in TSC-related epilepsy. $117.3 Million in Cash and Cash Equivalents at M ...

Researchers have gained comprehensive insights into the entire nervous system of the fruit fly (Drosophila melanogaster). The study describes in detail the neurons that span the entire nervous system ...

For the first time, researchers at Leipzig University and other institutions have gained comprehensive insights into the ...

New data show AAV-delivered antibody fragments targeting oxidized phosphatidylcholines (PC-OxPL), a species of oxidized ...

Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) ...

"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

Natural Combination of the Western Region's Leading Business Banks Builds Market Presence and Drives Financial Performance Steve Gardner, Chairman, President, and CEO of Pacific Premier, said, "We ...

After an initial 4–6 weeks of intravenous amphotericin B, transition to an oral azole agent to complete a minimum of 12 months of therapy is recommended, with voriconazole the preferred option for ...